Literature DB >> 3478194

Comparative biodistributions and rates of catabolism of radiolabelled anti-CEA monoclonal antibody and control immunoglobulin in nude mice with human tumour xenografts showing specific antibody localization.

M V Pimm1, R W Baldwin.   

Abstract

The rate of catabolism of a radiolabelled monoclonal anti-CEA antibody has been compared with that of control IgG1 in control nude mice and in mice with CEA producing xenografts and antigen negative xenografts. The rate of catabolism of antibody, but not of IgG, was increased 3-4 fold in mice with xenografts localizing the antibody, but not in mice with antigen negative tumours. There was no evidence of immune complex formation and/or clearance of antibody from the serum of xenografted mice and the current interpretation of these findings is that following tumour immune directed fixation, antibody is subsequently catabolized faster than in the general metabolic pool. The present data indicates that this is about six times as rapid as in the animal as a whole on a weight to weight tissue basis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3478194     DOI: 10.1007/BF00252604

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.

Authors:  M V Pimm; M J Embleton; A C Perkins; M R Price; R A Robins; G R Robinson; R W Baldwin
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

3.  Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts.

Authors:  M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1985

4.  Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen.

Authors:  L L Houston; R C Nowinski; I D Bernstein
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

5.  Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.

Authors:  J P Mach; F Buchegger; M Forni; J Ritschard; C Berche; J D Lumbroso; M Schreyer; C Girardet; R S Accolla; S Carrel
Journal:  Immunol Today       Date:  1981-12

6.  Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice.

Authors:  D A Scheinberg; M Strand
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

7.  Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice.

Authors:  T Motoyama; H Watanabe
Journal:  Gan       Date:  1983-10

8.  Radioiodinated B6.2 monoclonal antibody: further characterization of a potential radiopharmaceutical for the identification of breast tumors.

Authors:  M R Zalutsky; D Colcher; W D Kaplan; D W Kufe
Journal:  Int J Nucl Med Biol       Date:  1985

9.  Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.

Authors:  M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1987

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  3 in total

1.  Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice.

Authors:  M V Pimm; R A Robins; R W Baldwin
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Variations in radioimmunoscintigraphic detection of tumor showed by five monoclonal antibodies to carcinoembryonic antigen.

Authors:  K Kohno; K Nakata; Y Kusumoto; N Ishii; T Kohji; Y Matsuoka; S Nishi; S Nagataki
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

3.  Radiolocalisation and imaging of stably HPLAP-transfected MO4 tumours with monoclonal antibodies and fragments.

Authors:  P G Hendrix; S E Dauwe; A Van De Voorde; E J Nouwen; M F Hoylaerts; M E De Broe
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.